Startup Acquisitions 2026: Lilly’s $7B Bet And PE Carve-Outs

Apr 24, 2026
6 Deals Mentioned
$7.23B+ Disclosed Deal Value (Min.)
3 Sectors Touched
Eli Lilly Biggest Acquirer (by value)
By the time a deal is headline news, the best entry prices are already gone. The only edge left is pattern recognition: what acquirers are quietly signaling they’ll pay up for next.

In April 2026, the exit market isn’t “back” broadly — it’s selectively open for targets that either (a) compress time-to-value for strategics or (b) fit private equity’s operational playbook. The cleanest read: Eli Lilly’s plan to acquire Kelonia Therapeutics for up to $7 billion in cash is a reminder that when a strategic needs an asset, price sensitivity drops fast. Meanwhile, multiple PE-led transactions (including a Honeywell carve-out and three Ireland tuck-ins) show sponsors leaning into predictable integration and cash-flow scaling.

💡
Key Insight: This month’s deals are telling you where “non-linear” outcomes still exist in 2026: biotech platform buys (strategic urgency) and industrial/logistics carve-outs (PE process). Your job is to get in 12–24 months earlier, before the mandate becomes public.

1. Headline Deals

The highest-signal deals are the ones that either reset price ceilings (strategics paying for urgency) or confirm repeatable roll-up behavior (sponsors scaling platforms). April’s set is a mix of both.

Eli Lilly → Kelonia Therapeutics $7.0B (up to)
Oyo → G6 Hospitality (Motel 6 + Studio 6) $525M
Freshworks → Device42 $230M

Kelonia Therapeutics

Healthcare / Biotech (Gene therapy; cancer focus)

Eli Lilly announced it is acquiring Kelonia Therapeutics, a gene therapy developer with a particular focus on cancer treatment, in a deal valued at up to $7 billion in cash.

$7.0B Deal Value (up to)
Strategic Acquirer Type

Why it matters: Large-cash biotech acquisitions are the clearest indicator that select therapeutic modalities and pipelines are still commanding premium urgency. For early investors, the signal isn’t “biotech is hot,” it’s narrower: acquirers will pay when the asset collapses timelines to clinical/portfolio impact.

Device42

SaaS (IT infrastructure discovery / management)

Freshworks disclosed it is acquiring U.S.-based startup Device42 for $230 million (per SEC filing), alongside a CEO transition: Dennis Woodside appointed as new CEO and founder Girish Mathrubootham stepping down.

$230M Deal Value
Public SaaS Acquirer Profile

Why it matters: This is a classic “product surface area expansion” acquisition — buying an asset that makes the core platform stickier. The adjacent CEO change increases the probability that Freshworks is repositioning around platform breadth and enterprise credibility.

G6 Hospitality (Motel 6 + Studio 6)

Hospitality (Budget + extended-stay brands)

Oyo reached a deal to acquire G6 Hospitality, which operates Motel 6, for $525 million in an all-cash transaction from Blackstone Real Estate; includes the Studio 6 extended-stay brand.

$525M Deal Value
All-cash Consideration

Why it matters: This is a distribution + brand footprint play at a meaningful scale. For early-stage investors, it’s a reminder that “offline-heavy” categories can still produce large strategic transactions — but usually when a buyer can integrate demand generation, pricing, and operations across a large installed footprint.

Wonder Dynamics

AI / Media & Entertainment (VFX + character creation)

Autodesk acquired Wonder Dynamics, an AI-powered VFX startup enabling creators to make complex characters and visual effects using AI-powered image analysis.

Undisclosed Deal Value
Strategic Acquirer Type

WeTransfer

Apps / Creator tools (File transfer)

Bending Spoons acquired WeTransfer and said it will continue reserving 30% of WeTransfer’s advertising space for give back campaigns and editorial content.

Undisclosed Deal Value
Strategic Acquirer Type
💡
Key Insight: April’s headline deals cluster into two repeatable buyer motivations: (1) “pipeline urgency” (Lilly–Kelonia) and (2) “platform bundling” (Freshworks–Device42; Autodesk–Wonder Dynamics). If you want earlier entry points, screen for startups that either shorten time-to-market for incumbents or measurably increase platform attach.

2. Strategic Acquirer Activity

Strategics aren’t buying “innovation” in the abstract — they’re buying distribution leverage and time compression. In the provided deal set, we see three distinct strategic playbooks:

  • Pipeline acceleration in biotech: Eli Lilly’s up to $7B acquisition of Kelonia Therapeutics.
  • Enterprise platform expansion: Freshworks acquiring Device42 for $230M to broaden/strengthen its SaaS footprint.
  • Workflow embedding for creators: Autodesk acquiring Wonder Dynamics to bring AI-enabled VFX into its 3D tools ecosystem.
  • Audience + utility bundling: Bending Spoons acquiring WeTransfer, keeping a defined portion of ad inventory for campaigns/editorial.
AcquirerTargetDisclosed ValueCategory
Eli LillyKelonia Therapeutics$7.0B (up to)Healthcare / Biotech
FreshworksDevice42$230MSaaS
AutodeskWonder DynamicsUndisclosedAI / VFX
Bending SpoonsWeTransferUndisclosedApps / Creator tools
OyoG6 Hospitality (Motel 6 + Studio 6)$525MHospitality
💡
Key Insight: When strategics buy, they increasingly buy “integration-ready wedges” — products that can be embedded quickly into an existing distribution channel. For sourcing, prioritize startups that can show a clear attach path to a major platform’s existing buyers.

3. IPO & Public Market Activity

The provided news set doesn’t include any specific April 2026 IPOs, IPO filings, or post-IPO performance figures. That absence is a signal in itself: this roundup is dominated by M&A and sponsor-led transactions, not public listings.

From Crunchbase’s April 2026 commentary, the market message is consistent: venture can have a strong funding quarter while exit activity remains selective. Separately, Crunchbase also notes in EV that exit activity appears muted in that segment, reinforcing that public exits are not the default liquidity path in 2026 across categories.

EV segment (Crunchbase) Exit activity muted
💡
Key Insight: With IPO details absent here and M&A carrying the signal load, portfolio construction should assume “M&A-first liquidity” for most early-stage bets in 2026 — especially outside the narrow set of IPO-ready categories.

4. Private Equity Moves

PE is active where it can underwrite integration, margin improvement, and repeatable acquisition sourcing — not where the value creation depends on unpredictable adoption curves.

CES Power

Industrial services (Event/energy rental)

Allied Industrial-backed CES Power completed three acquisitions in Ireland: GH Energy Rental, Event Power, and Purecore.

3 Acquisitions (Ireland)
PE-backed Ownership

Honeywell warehouse and workflow solutions business (carve-out)

Logistics / Workflow solutions

AIP plans to acquire Honeywell’s warehouse and workflow solutions business in a carve-out transaction.

Carve-out Deal Type
AIP Buyer
💡
Key Insight: PE activity here is not “betting on innovation” — it’s buying operationally legible assets (carve-outs) and stacking tuck-ins (CES Power). For early-stage investors, this is a roadmap: build in categories where consolidation math works, and you’ll have more exit paths.

Even with a small sample, April’s deal mix points to where acquirers are consistently allocating: healthcare platform assets, enterprise SaaS infrastructure, AI tooling inside established workflows, and industrial/logistics systems that fit carve-out and roll-up models.

SectorDeals (from provided articles)ExamplesBuyer Type
Healthcare / Biotech1Lilly → Kelonia TherapeuticsStrategic
SaaS1Freshworks → Device42Strategic (public)
AI in Media Tools1Autodesk → Wonder DynamicsStrategic
Creator / Utility Apps1Bending Spoons → WeTransferStrategic
Logistics / Workflow (Industrial)1AIP → Honeywell warehouse & workflow solutions businessPrivate equity
Industrial services1 (platform with 3 tuck-ins)CES Power → GH Energy Rental; Event Power; PurecorePrivate equity-backed
Healthcare (single deal, outsized value) $7.0B (up to)
SaaS infrastructure (platform expansion) $230M
📚 Case Study
How Freshworks used M&A to expand platform surface area

Freshworks’ $230M acquisition of Device42 is a clean example of “attachable capability”: acquire a product that strengthens enterprise workflows and increases platform stickiness. For early investors, the playbook is to back startups that map directly onto a platform’s upsell motion — the acquirer can underwrite revenue synergy faster than it can build from scratch.

💡
Key Insight: The highest-probability 12–24 month acquisition targets are often the “missing module” inside an incumbent workflow (Device42; Wonder Dynamics) or the “must-have pipeline asset” when a strategic is time-constrained (Kelonia).

6. Valuation Insights

We only have three disclosed price points in the provided dataset: $7.0B (up to), $525M, and $230M. That’s still enough to extract one useful conclusion for early-stage underwriting in 2026:

  • Strategic urgency still creates price discontinuities: Lilly–Kelonia shows that buyers will pay “category-defining” prices when the asset is strategically scarce.
  • Mid-market platform deals remain alive: Freshworks–Device42 at $230M is a reminder that sub-$500M outcomes are still realistic for enterprise assets with clear integration value.
  • Scale assets trade even when they’re not software: Oyo’s $525M all-cash agreement highlights that large operational footprints can command meaningful prices when they unlock distribution and cross-market synergies.
💡
Key Insight: In 2026, valuation isn’t primarily a function of buzz — it’s a function of whether the asset can be integrated fast and whether it removes strategic constraints. Underwrite “integration velocity,” not narratives.

7. What This Means for Your Portfolio

If you’re building an early-stage portfolio optimized for exits (not just markups), April’s deals give you a practical checklist for what to buy earlier than everyone else.

  • Bias toward “module businesses” with natural acquirers: Device42-like assets win when they plug into a platform’s sales motion.
  • In healthcare, hunt for urgency pockets: Kelonia’s up to $7B outcome signals that the right therapeutic focus can still trigger premium strategic bids.
  • Track PE roll-up categories: CES Power’s three acquisitions show how quickly a platform can consolidate a niche. Startups that become must-have service layers in consolidating categories can exit earlier than “standalone winners.”
  • Don’t ignore carve-out adjacency: AIP’s Honeywell carve-out points to sustained demand for warehouse/workflow modernization assets around industrial incumbents.
💡
Key Insight: The fastest way to get “early” in 2026 is to map buyer mandates before they hit the press: list the top 20 strategics in a sector, identify their workflow gaps, then back startups that can be embedded in <12 months.

Action you can take this week: Build a watchlist around (1) enterprise infrastructure modules, (2) AI tools embedded into incumbent creator/production workflows, and (3) operational categories showing repeated tuck-in acquisition behavior. If you want our newest M&A-driven screens and early signals, explore EarlyFinder membership.

See plans on /pricing or return to homepage.